ADJUVANT THERAPY WITH TAMOXIFEN IN OPERABLE BREAST CANCER: 10 year results of the Naples (GUN) study
- 12 November 1988
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 332 (8620), 1095-1099
- https://doi.org/10.1016/s0140-6736(88)90521-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The Stockholm trial on adjuvant tamoxifen in early breast cancerBreast Cancer Research and Treatment, 1987
- Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.Journal of Clinical Oncology, 1986
- Adjuvant Tamoxifen Treatment of Elderly Women with Stage II Breast CancerAnnals of Internal Medicine, 1985
- The Christie Hospital Tamoxifen (Nolvadex) adjuvant trial for operable breast carcinoma - 7-yr resultsEuropean Journal of Cancer and Clinical Oncology, 1985
- Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1985
- BENEFICIAL EFFECT OF ADJUVANT TAMOXIFEN THERAPY IN PRIMARY BREAST CANCER PATIENTS WITH HIGH OESTROGEN RECEPTOR VALUESThe Lancet, 1985
- ADJUVANT HORMONAL CHEMOTHERAPY IN EARLY BREAST CANCER: EARLY RESULTS FROM A CONTROLLED TRIALThe Lancet, 1984
- Antiestrogen treatment of postmenopausal women with primary high risk breast cancerBreast Cancer Research and Treatment, 1983
- Unbiased assessment of treatment effects on disease recurrence and survival in clinical trialsStatistics in Medicine, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958